JP2016520603A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520603A5
JP2016520603A5 JP2016516143A JP2016516143A JP2016520603A5 JP 2016520603 A5 JP2016520603 A5 JP 2016520603A5 JP 2016516143 A JP2016516143 A JP 2016516143A JP 2016516143 A JP2016516143 A JP 2016516143A JP 2016520603 A5 JP2016520603 A5 JP 2016520603A5
Authority
JP
Japan
Prior art keywords
composition
rutin
composition according
curcumin
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016516143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520603A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/061022 external-priority patent/WO2014191448A1/en
Publication of JP2016520603A publication Critical patent/JP2016520603A/ja
Publication of JP2016520603A5 publication Critical patent/JP2016520603A5/ja
Pending legal-status Critical Current

Links

JP2016516143A 2013-05-29 2014-05-28 軟骨破壊における使用のための組成物 Pending JP2016520603A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13169653.6 2013-05-29
EP13169653 2013-05-29
PCT/EP2014/061022 WO2014191448A1 (en) 2013-05-29 2014-05-28 Compositions for use in cartilage breakdown

Publications (2)

Publication Number Publication Date
JP2016520603A JP2016520603A (ja) 2016-07-14
JP2016520603A5 true JP2016520603A5 (enExample) 2017-07-06

Family

ID=48485058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016516143A Pending JP2016520603A (ja) 2013-05-29 2014-05-28 軟骨破壊における使用のための組成物

Country Status (8)

Country Link
US (1) US20160101125A1 (enExample)
EP (1) EP3003338A1 (enExample)
JP (1) JP2016520603A (enExample)
CN (1) CN105246499A (enExample)
AU (1) AU2014273186A1 (enExample)
BR (1) BR112015029354A2 (enExample)
CA (1) CA2913621A1 (enExample)
WO (1) WO2014191448A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2912957A1 (en) * 2013-05-29 2014-12-04 Nestec S.A. Compositions for use in cartilage breakdown
JP2021502064A (ja) * 2017-11-08 2021-01-28 ソシエテ・デ・プロデュイ・ネスレ・エス・アー プロバイオティクスを選択する方法
JP2021502335A (ja) * 2017-11-08 2021-01-28 ソシエテ・デ・プロデュイ・ネスレ・エス・アー オレウロペインの生物変換
US20210169826A1 (en) * 2017-11-08 2021-06-10 Societe Des Produits Nestle S.A. Homovanillyl alcohol (hva), hva isomer, methods of making compositions comprising such compounds, and methods using such compounds
ES2967899T3 (es) * 2017-11-08 2024-05-06 Nestle Sa Bioconversión de oleuropeína
CN108686119A (zh) * 2018-06-27 2018-10-23 陶燃 一种治疗痛风的药物组合物及其应用
WO2021024801A1 (ja) * 2019-08-02 2021-02-11 サントリーホールディングス株式会社 軟骨再生促進用組成物
AU2020406604A1 (en) * 2019-12-17 2022-07-07 Suntory Holdings Limited Composition for promoting chondroitin sulfate synthesis
AU2021228197A1 (en) * 2020-02-28 2022-07-07 Biosearch, S.A. Uses and compositions based on polyphenols for improving the oral bioavailability of hydroxytyrosol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
JP4592249B2 (ja) * 2001-11-30 2010-12-01 江崎グリコ株式会社 リウマチの症状改善用飲食品および医薬
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
KR101563528B1 (ko) * 2006-02-10 2015-10-27 마나테크, 인코포레이티드 흡수 및 생물학적 이용 증진을 위한 완전 천연 종합 비타민 및 종합 미네랄 건강 보조제
KR101435228B1 (ko) * 2006-07-14 2014-08-28 디에스엠 아이피 어셋츠 비.브이. 조성물, 및 염증성 질환의 치료, 병용-치료 또는 예방을 위한 이의 용도
CA2623733A1 (en) * 2007-03-02 2008-09-02 Sam Ziff Supplements for pain management
US7871609B2 (en) * 2007-03-02 2011-01-18 Sam Ziff Supplements for pain management
US8815306B2 (en) * 2007-03-19 2014-08-26 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
EP2229940B1 (en) * 2009-03-20 2015-07-01 Bioxtract S.A. Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
CA2912957A1 (en) * 2013-05-29 2014-12-04 Nestec S.A. Compositions for use in cartilage breakdown

Similar Documents

Publication Publication Date Title
JP2016520603A5 (enExample)
NZ769177A (en) Cannabis extracts and methods of preparing and using same
BR112012026758A2 (pt) cápsula, método para produzir cápsulas com uma estrutura de núcleo/envoltório, usos de cápsulas com uma estrutura de núcleo/envoltório, e de preparações pulverulentas ou líquidas, e, composição farmacêutica, de cosméticos, preparação de proteção de cultura, alimentação de animal, suplemento alimetar ou nutricional
AR056081A1 (es) Composicion que es posible de dispersar en agua y metodo para prepararla
CL2015003545A1 (es) Una capsula para preparar composiciones comestibles
WO2011036316A3 (es) Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen
BR112017003346B8 (pt) Derivados de pirazolopiridina, seus usos, e composição farmacêutica
CU20170031A7 (es) Sacáridos y mezclas y composiciones de sacáridos
BR112012030581A2 (pt) pseudozyma aphidis como um agente de biocontrole contra vários patógenos de plantas
NO20075540L (no) Lignian-inneholdende sammensetninger
CL2019001194A1 (es) Extracto de una composición herbal como agente antimicrobiano y/o antibiopelícula.
MX356589B (es) Formulaciones nutricionales en polvo que incluyen proteina vegetal secada por aspersion.
WO2011059292A3 (ko) 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
MX387386B (es) Sistema de alimentacion para mascotas.
PT3279210T (pt) Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativo
MX2018004796A (es) Conservacion de vitaminas hidrosolubles.
WO2012050398A3 (ko) 생약 추출물을 포함하는 폐암 예방 또는 치료용 약학적 조성물
MX2010009314A (es) Polifenoles para el tratamiento de padecimientos de cartilago.
WO2012050397A3 (ko) 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물
BR112013013908A2 (pt) produtos alimentícios para crianças compreendendo grãos integrais hidrolisados
BR112013002832A2 (pt) composição compreendendo retinol, um precursor ou um produto de reação do mesmo e um extrato vegetal de pelo menos uma planta de camomila para o tratamento de câncer
CL2017001472A1 (es) Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia.
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2008126367A1 (ja) 精神安定剤および機能性食品
AR093103A1 (es) COMPOSICION A BASE DE HIERBAS PARA LA PREVENCION Y TRATAMIENTO DE FACTOR a DE NECROSIS TUMORAL (TNF-a) UNA ENFERMEDAD MEDIADA